Literature DB >> 3054362

Peripheral diabetic neuropathy.

H E Bays1, M A Pfeifer.   

Abstract

Diabetic neuropathy is a common complication of diabetes mellitus with significant morbidity and mortality. Hyperglycemia with its secondary metabolic, vascular, and enzymatic consequences is most likely to be the predominant cause. The clinical manifestations includes a wide range of somatic and autonomic syndromes. Painful diabetic neuropathy may require symptomatic treatment. The precise role of therapies such as continuous subcutaneous insulin therapy and aldose reductase inhibitors remains to be clarified.

Entities:  

Mesh:

Year:  1988        PMID: 3054362     DOI: 10.1016/s0025-7125(16)30716-7

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

1.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

2.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

3.  Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy?

Authors:  M J Young; A Veves; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

4.  Prognostic implication of gastroparesis in patients with diabetes mellitus.

Authors:  T K Chaudhuri; S Fink
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

5.  CARDIAC AUTONOMIC NEUROPATHY IN DIABETES MELLITUS.

Authors:  A S Kasthuri; Rps Yadav
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 6.  Diabetic neuropathy in elderly patients. What can be done?

Authors:  J Belmin; P Valensi
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.